GlycoNet and Partners Invest $7.7 Million in Canadian Health Innovation
This investment will support state-of-the-art health research for Canada’s leading diseases, including cancer, diabetes, dementia, muscular dystrophy and universal donor blood. EDMONTON, April 20, 2022 –GlycoNet, one of the world’s leaders in glycomics research and […]